A novel TYK2 inhibitor may provide clinicians with another treatment option along the janus kinase pathway in patients with severe #psoriasis, said Dr. George Martin at #RWCS2020 @RWCSmtg https://t.co/i630rfoxnl
Links:
Novel TYK2 inhibitor may be a ‘game changer’ for psoriasis
https://www.healio.com/rheumatology/psoriatic-arthritis/news/online/%7B3944516f…
Feb-15-2020
